63539-252-02 |
63539-252 |
HUMAN PRESCRIPTION DRUG |
Elrexfio |
elranatamab-bcmm |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20230815 |
N/A |
BLA |
BLA761345 |
U.S. Pharmaceuticals |
ELRANATAMAB |
44 mg/1.1mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01) |
0069-2522-02 |
0069-2522 |
HUMAN PRESCRIPTION DRUG |
Elrexfio |
elranatamab-bcmm |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20230815 |
N/A |
BLA |
BLA761345 |
Pfizer Laboratories Div Pfizer Inc |
ELRANATAMAB |
44 mg/1.1mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01) |
0069-4494-02 |
0069-4494 |
HUMAN PRESCRIPTION DRUG |
Elrexfio |
elranatamab-bcmm |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20230815 |
N/A |
BLA |
BLA761345 |
Pfizer Laboratories Div Pfizer Inc |
ELRANATAMAB |
76 mg/1.9mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (0069-4494-02) / 1.9 mL in 1 VIAL, SINGLE-DOSE (0069-4494-01) |